+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Urinary Tract Infection Market by Treatment, Distribution Channel, End User, Type, Patient Type, Age Group, Gender - Global Forecast to 2030- Product Image
Urinary Tract Infection Market by Treatment, Distribution Channel, End User, Type, Patient Type, Age Group, Gender - Global Forecast to 2030- Product Image
Sale

Urinary Tract Infection Market by Treatment, Distribution Channel, End User, Type, Patient Type, Age Group, Gender - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4986010
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The urinary tract infection (UTI) market is evolving rapidly as new therapies, technological advancements, and changes in regulatory policy drive transformation across the global healthcare environment. With increased emphasis on resistance management and patient-centric treatment pathways, senior decision-makers need actionable insights to navigate complexities and optimize strategy.

Market Snapshot: Urinary Tract Infection Market Trends

The Urinary Tract Infection (UTI) Market grew from USD 12.47 billion in 2024 to USD 13.34 billion in 2025. It is expected to continue growing at a CAGR of 6.96%, reaching USD 18.68 billion by 2030. This growth reflects broader sectoral momentum due to advancing diagnostic technologies, expanded therapeutic portfolios, and strategic responses to increased antibiotic resistance. Market activity is further influenced by expanded payer involvement, shifts in patient demographics, and evolving supply chain logistics.

Scope & Segmentation

This report offers an in-depth analysis across a comprehensive array of segments and geographies, equipping decision-makers with detailed insight into current and emerging opportunities:

  • Treatment Types: Antibiotics (Fosfomycin, Nitrofurantoin, Trimethoprim/Sulfamethoxazole); Non-Antibiotic Therapies (D-Mannose, Phenazopyridine, Probiotics)
  • Distribution Channels: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
  • End Users: Clinics, Home Care Settings, Hospitals
  • Infection Type: Complicated, Uncomplicated
  • Patient Categories: Recurrent, Single Episode
  • Age Groups: Adults, Geriatrics, Pediatrics
  • Gender: Female, Male
  • Regional Coverage: Americas (including U.S. states such as California, Texas, New York), Europe, Middle East & Africa (key countries: United Kingdom, Germany, South Africa), Asia-Pacific (including China, India, Japan, Australia)
  • Company Profiles: Pfizer Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., GlaxoSmithKline plc, Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, Astellas Pharma Inc., Bayer AG

Key Takeaways for Decision-Makers

  • Adoption of non-antibiotic therapies is accelerating, particularly as adjuncts or alternatives to traditional antibiotics, broadening market options and supporting resistance stewardship.
  • Digital health platforms, such as telemedicine and remote monitoring applications, are increasingly instrumental in monitoring symptoms and improving adherence, providing new touchpoints across the patient journey.
  • Clinical advances and regulatory adjustments are facilitating faster pathways for therapy approval and market entry, supporting innovation in both antibiotic and non-antibiotic categories.
  • Integrated supply chain strategies, including local manufacturing and alternative sourcing, are reinforcing business resilience against global disruptions and tariff changes.
  • Demographic segmentation reveals high-value subpopulations, such as geriatric recurrent cases and females with single-episode infections, requiring tailored therapies and distribution models.
  • Strategic alliances, consolidations, and licensing deals are reshaping the competitive landscape, allowing established and emerging firms to leverage synergies and expedite innovation pipelines.

Tariff Impact Across U.S. Infection Management

Recent U.S. tariff escalations have introduced significant cost pressures across the pharmaceutical supply chain. These developments affect both antibiotic manufacturers and suppliers of key non-antibiotic raw materials used for therapies such as D-mannose and phenazopyridine. Industry responses include diversifying sourcing, repatriating production, and advocating for policy reform to help mitigate risk and ensure continual market access. These measures are particularly relevant for organizations exposed to shifts in global trade policy and raw material pricing, necessitating agile adjustment of both R&D and commercial strategies.

Methodology & Data Sources

This report is built on a dual-pronged methodology, combining thorough secondary research from peer-reviewed journals, federal agency publications, and industry databases with primary interviews of clinical leaders, industry executives, and healthcare practitioners. Survey feedback and data triangulation ensure robust validation of segmentation and regional insights. All research steps comply with ethical standards, including anonymized participant data and transparent disclosure of study limitations.

Why This Report Matters

  • Enables senior leaders to identify and act on trends affecting drug portfolios, regulatory risk, and patient engagement strategies within the urinary tract infection market.
  • Supports proactive resource allocation across regions, segmentation, and emerging technologies for a balanced approach to innovation and supply chain resilience.
  • Equips executives to align product development and market access plans with shifts in both healthcare policy and evolving patient preferences, maximizing competitive advantage.

Conclusion

This report provides strategic clarity on the forces reshaping the urinary tract infection market. Stakeholders will find actionable guidance to navigate change, enhance operational resilience, and seize new opportunities in a transformative sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Urinary Tract Infection Market, by Treatment
8.1. Introduction
8.2. Antibiotics
8.2.1. Fosfomycin
8.2.2. Nitrofurantoin
8.2.3. Trimethoprim/Sulfamethoxazole
8.3. Non Antibiotic Therapies
8.3.1. D Mannose
8.3.2. Phenazopyridine
8.3.3. Probiotics
9. Urinary Tract Infection Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Urinary Tract Infection Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care Settings
10.4. Hospitals
11. Urinary Tract Infection Market, by Type
11.1. Introduction
11.2. Complicated
11.3. Uncomplicated
12. Urinary Tract Infection Market, by Patient Type
12.1. Introduction
12.2. Recurrent
12.3. Single Episode
13. Urinary Tract Infection Market, by Age Group
13.1. Introduction
13.2. Adults
13.3. Geriatrics
13.4. Pediatrics
14. Urinary Tract Infection Market, by Gender
14.1. Introduction
14.2. Female
14.3. Male
15. Americas Urinary Tract Infection Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Urinary Tract Infection Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Urinary Tract Infection Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Pfizer Inc.
18.3.2. F. Hoffmann-La Roche Ltd
18.3.3. Johnson & Johnson
18.3.4. Merck & Co., Inc.
18.3.5. GlaxoSmithKline plc
18.3.6. Abbott Laboratories
18.3.7. Thermo Fisher Scientific Inc.
18.3.8. Danaher Corporation
18.3.9. Astellas Pharma Inc.
18.3.10. Bayer AG
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. URINARY TRACT INFECTION MARKET MULTI-CURRENCY
FIGURE 2. URINARY TRACT INFECTION MARKET MULTI-LANGUAGE
FIGURE 3. URINARY TRACT INFECTION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL URINARY TRACT INFECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 20. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. URINARY TRACT INFECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. URINARY TRACT INFECTION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. URINARY TRACT INFECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL URINARY TRACT INFECTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FOSFOMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NITROFURANTOIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TRIMETHOPRIM/SULFAMETHOXAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY D MANNOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PHENAZOPYRIDINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY COMPLICATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY UNCOMPLICATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY RECURRENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY SINGLE EPISODE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. CANADA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 59. CANADA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 60. CANADA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 61. CANADA URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. CANADA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. CANADA URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. CANADA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 66. CANADA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 67. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 70. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 113. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 114. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 115. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 116. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 123. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 124. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 125. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 130. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 140. ITALY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 141. ITALY URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 142. ITALY URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 143. ITALY URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. ITALY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. ITALY URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. ITALY URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. ITALY URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. ITALY URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 149. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 151. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 152. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 156. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 185. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 186. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 187. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 188. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 192. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 193. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 203. QATAR URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 204. QATAR URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 205. QATAR URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 206. QATAR URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. QATAR URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. QATAR URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. QATAR URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 210. QATAR URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 211. QATAR URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 212. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 213. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 214. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 215. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 219. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 239. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 240. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 241. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 242. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 246. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 247. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 248. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 249. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 250. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 251. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 254. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 255. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 256. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 266. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 267. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 268. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 269. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 272. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 273. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 275. POLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 276. POLAND URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 277. POLAND URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 278. POLAND URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. POLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. POLAND URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 281. POLAND URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 282. POLAND URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 283. POLAND URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 284. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 285. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 303. CHINA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 304. CHINA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 305. CHINA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 306. CHINA URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. CHINA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. CHINA URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 309. CHINA URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 310. CHINA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 311. CHINA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 312. INDIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 313. INDIA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 314. INDIA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 315. INDIA URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. INDIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. INDIA URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 318. INDIA URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 319. INDIA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 320. INDIA URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 321. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 322. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 323. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 324. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 327. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 328. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 329. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 330. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 331. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 332. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 333. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA URINARY TRACT IN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Urinary Tract Infection market report include:
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Astellas Pharma Inc.
  • Bayer AG

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 13.34 Billion
Forecasted Market Value ( USD ) by 2030 $ 18.68 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Urinary Tract Infection Treatment - Global Strategic Business Report - Product Image

Urinary Tract Infection Treatment - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Urinary Tract Infection Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Urinary Tract Infection Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 112 Pages
  • Global
From
Urinary Tract Infection (UTI) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company) - Product Image

Urinary Tract Infection (UTI) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company)

  • Report
  • 210 Pages
  • Global
From
Uncomplicated Urinary Tract Infection Treatment Market Report 2025 - Product Image

Uncomplicated Urinary Tract Infection Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Urinary Tract Infection Treatment Market Report 2025 - Product Image

Urinary Tract Infection Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Urinary Tract Infection Drug Market

The Urinary Tract Infection Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urinary tract infections (UTIs), which are caused by bacteria entering the urinary tract. These drugs are typically antibiotics, such as sulfonamides, cephalosporins, and fluoroquinolones. They are used to kill the bacteria and reduce the symptoms of the infection. Other drugs, such as antifungals, may also be used to treat UTIs. The Urinary Tract Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. These companies are constantly developing new drugs to treat UTIs, as well as other urological disorders. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.